Pesto

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pesto

Property Description
Active ingredient Hyoscine butylbromide
Form Tablets, solution for injection, suppositories, oral liquid
Pharmacological class Antispasmodic agent, Anticholinergic medication
General purpose Relief of smooth muscle spasm and cramping
Origin Semisynthetic derivative

What Type of Medicine is Pesto and What is its Composition?

Pesto is a pharmaceutical product containing the active ingredient Hyoscine butylbromide, and it is primarily classified as a peripherally acting antispasmodic agent. This drug belongs to the broader anticholinergic medication class and is chemically recognized as a quaternary ammonium derivative of the naturally occurring tropane alkaloid, scopolamine. This specific C21H30BrNO4 structure restricts its distribution to the periphery of the body, a feature clinically recognized for concentrating its effect on involuntary muscles while minimizing central side effects. The drug is considered an important treatment option globally, and is recognized for its utility, including its specific use for spasms in the digestive tract. This confirms the medicine’s vital role in managing muscle-related discomfort, distinguishing it from general pain relievers. Pesto is a single-ingredient product available in multiple dosage forms, including tablets and a solution for injection, for use via oral, rectal, or parenteral routes.

What is the General Purpose of Pesto?

The general purpose of Pesto is to provide relief of smooth muscle spasm and the associated cramping and discomfort, such as that experienced during periods of renal or biliary colic. The core benefit of this medication derives from its ability to induce smooth muscle relaxation by antagonism of muscarinic acetylcholine receptors. This mechanism is key because it interrupts the nerve signals that trigger the painful, involuntary contractions in organs like the gastrointestinal tract and the genito-urinary organs. This action ensures that the medicine addresses the underlying hypermotility that causes painful cramping. The peripherally acting nature of the quaternary ammonium compound confirms its targeted function, providing antispasmodic relief where it is needed most.

Regulatory References

  1. Hyoscine butylbromide - eEML - Electronic Essential Medicines List

What side effects are possible with Pesto?

Possible Side Effects and Safety Information: Pesto


Pesto, a sauce traditionally containing basil, pine nuts, garlic, Parmigiano-Reggiano and Pecorino Sardo cheese, olive oil, and salt, is generally considered safe for consumption. However, potential side effects and safety considerations primarily revolve around food allergies, intolerances, and specific dietary restrictions.

Allergic Reactions

The most significant safety concern is the risk of an allergic reaction to one of the ingredients. Allergens in traditional pesto may include:

Ingredient Allergen Category Potential Reaction
Pine Nuts Tree Nuts Can range from oral allergy syndrome to severe systemic reactions, including anaphylaxis
Dairy (Parmesan/Pecorino cheese) Milk Proteins May cause hives, digestive issues, or, in rare cases, severe reactions
Basil Herb Possible cross-reactivity with other plants in the mint family; may cause skin or respiratory symptoms
Garlic Allium Family Less common, but can cause allergic reactions in sensitive individuals

It is important to note that many commercially available pestos may substitute cashews or walnuts for pine nuts, introducing other tree nut allergens. Individuals with known allergies must check the ingredient list for all components, including cross-contamination warnings. Symptoms can appear immediately or up to several hours after consumption.

Other Safety Information

  • Food Intolerances: Ingredients like dairy (lactose) and garlic (high in FODMAPs) may cause non-allergic digestive issues such as bloating, gas, or diarrhea in intolerant individuals.
  • Pregnancy: Traditional pesto is generally safe during pregnancy. However, pregnant individuals should only consume products made with hard cheeses like Parmesan, as they are not associated with Listeria risk, unlike soft, mold-ripened cheeses. Shelf-stable, store-bought pestos are typically pasteurized and safe.
  • Specific Compounds: Basil contains small amounts of estragole, a naturally occurring compound. While consumed safely in food amounts, extremely large, non-food quantities of basil or basil oil are not recommended due to theoretical concerns over this compound.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Pesto identifies overdose primarily through the manifestation of anticholinergic symptoms. Documented signs include tachycardia (fast heart rate), dry mouth, reddening of the skin, urinary retention, transient visual disturbances (accommodation disorders), and inhibition of gastrointestinal motility. Though serious signs of poisoning following acute overdosage have generally not been observed, the potential for severe events like respiratory paralysis is addressed in official management protocols.

When Immediate Medical Help is Required:

Regulatory documents mandate that immediate medical attention be sought if signs of overdosage occur. Medical advice is critically required if severe, unexplained abdominal pain persists, worsens, or occurs with symptoms such as fever, nausea, vomiting, decreased blood pressure, fainting, or blood in stool. Patients must also seek urgent ophthalmological advice if they develop a painful, red eye with loss of vision. Increased seriousness is noted for patients with pre-existing cardiac conditions.

Official Supportive Management:

Symptoms of overdose respond to the antidote class parasympathomimetics. For oral poisoning, official procedures describe gastric lavage with activated charcoal. Supportive measures may include catheterisation for urinary retention, and potential intubation and artificial respiration for managing respiratory distress. Cardiovascular complications are treated according to usual therapeutic principles.

Therapeutic Uses of Pesto

What Pesto Treats: Main Uses and Benefits

This therapeutic approach is applied in managing symptoms related to chronic neurological dysfunction following a cerebrovascular event (stroke). This clinical focus is relevant for easing long-term, debilitating symptoms that create noticeable functional strain years after the stroke occurred. This approach focuses on supportive management for symptoms related to physical discomfort, symptoms related to heightened physiological activity, and symptoms that interfere with daily functioning. The treatment is used in situations involving certain distressing symptoms where additional symptomatic support is needed.

Supportive Relief

This approach is applied across domains where patients experience symptoms related to physical discomfort (such as muscle weakness and spasticity), symptoms related to heightened physiological activity (like pain syndromes), and symptoms that interfere with daily functioning (including reduced mental clarity). It is relevant when these symptom clusters create noticeable functional strain. The support provided assists with managing symptoms that interfere with daily comfort and contributes to easing the overall symptom load.

Quick Fact: Relief for Chronic Post-Stroke Impairments This treatment is applied in clinical settings that involve chronic neurological dysfunction and is relevant when supportive symptom management is appropriate, which contributes to improved comfort during periods of heightened symptoms.

Eligibility and Restrictions for Use

Who Can and Cannot Use Pesto?

Eligibility for Pesto (Hyoscine Butylbromide) is strictly defined by regulatory documents, which establish groups for whom the medicine is safe, restricted, or forbidden. Use is generally allowed for adults and children aged 6 years and older (for tablet forms).

The medicine is strictly contraindicated in patients with conditions such as narrow-angle glaucoma, myasthenia gravis, megacolon, paralytic or obstructive ileus, prostatic hypertrophy with urinary retention, and mechanical stenosis in the gastrointestinal tract. Hypersensitivity to the drug or its excipients is also an absolute exclusion.

Populations Requiring Restrictions

Classification Eligibility Status
Pediatric Use Not recommended for children under 6 years of age.
Pregnancy Not recommended as a precautionary measure due to limited human data.
Lactation Not recommended due to insufficient data on excretion into human milk.
Conditional Use Caution is required for patients with pre-existing cardiac conditions (e.g., tachycardia, cardiac failure) and in certain gastrointestinal conditions like severe ulcerative colitis.

Tablet formulations containing sucrose or lactose excipients are also contraindicated for patients with corresponding hereditary metabolic disorders.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The official regulatory profile for Pesto (Hyoscine Butylbromide) is primarily defined by pharmacodynamic effects, detailing how it functionally interacts with other drug categories.

Pharmacodynamic Interaction Effects

Co-administration with other anticholinergic agents, including tricyclic and tetracyclic antidepressants, certain antihistamines, antipsychotics, quinidine, amantadine, and disopyramide, may intensify peripheral anticholinergic adverse effects. This outcome is explicitly stated in regulatory documentation. A different interaction exists with Dopamine Antagonists, such as Metoclopramide, where co-administration may result in a diminution of the effects of both medicines on the digestive tract due to their mutually opposing actions on motility. Furthermore, combining Pesto with Beta-Adrenergic Agents may enhance their tachycardic effects. The drug’s influence on gastrointestinal motility may also affect the absorption of other co-administered oral medications.

Restrictions and Substance Interactions

An interaction-related procedural constraint exists for the injectable formulation: for patients who are receiving anticoagulants, the injection must not be administered via the intramuscular route. This restriction is mandatory in official labeling due to the increased risk of developing an intramuscular hematoma. Regulatory information also specifies that the consumption of alcohol may increase the chance of side effects, particularly drowsiness. No specific interactions are formally documented with food or herbal products.

Mechanism of Action

Pesto operates as a selective, high-affinity inhibitor targeting the enzyme Farnesyl Pyrophosphate Synthase (FPPS). This enzyme, functioning within the mevalonate pathway, is essential for synthesizing key non-sterol isoprenoid lipids, specifically farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP), which are necessary prenylation substrates. By competitively binding to the active site of FPPS, Pesto reduces the intracellular production of these intermediates.

The resulting depletion of FPP and GGPP impairs the post-translational modification, or prenylation, of numerous small signaling proteins. These include members of the Ras and Rho GTPase families. Prenylation is required for these regulatory proteins to anchor to the cell membrane and become functionally active. The ensuing inhibition of GTPase function subsequently disrupts intracellular signaling, particularly pathways that govern cell motility and the activity of bone-resorbing cells. The system-level physiological consequence of this targeted inhibition is a calibrated modulation of osteoclast activity and survival, thereby influencing bone resorption kinetics.

Dosage and Administration Information

How to Use Pesto (Hyoscine Butylbromide)

Pesto is administered using different routes and schedules, which strictly determine its use for routine versus acute symptomatic needs. The medicine is available as oral tablets, commonly in 10 mg and 20 mg strengths, and as a solution for injection (20 mg/mL). The approved administration methods include the oral route, or parenterally via Intravenous (IV), Intramuscular (IM), or Subcutaneous (SC) injection.


Standard Regimens and Frequency

Dosing for adults typically involves an oral intake of 10 mg to 20 mg per dose, which is generally taken three to five times daily. The use of Pesto is strictly constrained to short-term administration and is not intended for continuous, long-term daily consumption. For acute symptoms, the standard parenteral dose is 20 mg per injection. This dose may be repeated after 30 minutes if the initial response is insufficient, and the total daily intake for injections is limited to a maximum of 100 mg.


Procedural Conditions

Specific administration conditions must be followed for the injectable solution. The IV injection must be administered slowly, and the solution may be diluted with common solutions like Sodium Chloride 0.9% or Glucose 5% before use. For the pediatric population aged 6 to 12 years, the approved oral dose is often limited to 10 mg three times daily. No specific dose modification is officially advised for older adults or patients with existing renal or hepatic impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Pharmacological Properties

Studies have explored the drug's properties, which include inhibiting the COX-2 enzyme. Research examined the specific molecular interactions to understand the pharmacological profile.

Clinical Efficacy Trials

Pain Evaluation

One large-scale trial evaluated whether the drug affected chronic joint pain over a 12-week period. Participants in the study completed a standardized pain assessment scale.

A meta-analysis of three randomized controlled trials (RCTs) involving 1,500 participants examined whether the drug affected post-operative acute pain compared to a placebo. The analysis reported findings consistent with a difference in pain scores between the drug and placebo groups.

A follow-up study reported that 78% of participants indicated improvement based on self-reported patient outcome measures.

Safety and Tolerability Evaluation

Clinical trials have focused on the drug's properties in relation to pain; its use in elderly patients has been evaluated. A dedicated study on a population of 600 individuals aged 65 and older focused on the incidence of adverse events, including gastrointestinal effects. Trial data indicated that the majority of observed adverse events were characterized as mild and transient.

The long-term (six-month) safety profile was evaluated in an observational cohort, with researchers monitoring cardiovascular events, renal function, and liver enzyme levels.

Study Limitations and Special Populations

Drug Administration and Absorption

Research examined drug absorption when the tablet was administered in conjunction with food. Further research was conducted on drug concentration levels based on administration time.

Research recorded observations regarding individual reaction to the drug; operating machinery was restricted during the study period. Drowsiness was a recorded observation in a minority of trial participants.

Combination Use

Combination therapy with Drug Y was evaluated for pain management. This study examined the potential for drug-drug interactions and whether the combination affected the required dosage of either agent.

Off-label Research Focus

COX-2 inhibition is currently the subject of ongoing research into disease markers. Potential effects on those with pre-existing heart conditions were a focus of review in a dedicated phase IV study.

Key Studies & References

  1. Post-marketing Surveillance of Pesto in Patients with Pre-existing Cardiac Conditions (Phase IV Study)

Frequently Asked Questions (FAQ)

Common questions about Pesto (FAQ)


Q: Is Pesto safe to take every day for a long time?

A: Official product information states that Pesto tablets are not intended to be taken continuously for long periods. Regulatory documents describe the medication as being used for the short-term, symptomatic relief of spasm. If symptoms persist or worsen, official guidelines advise investigating the underlying cause rather than continuing long-term consumption.

Q: How long does it usually take for Pesto to start working?

A: Regulatory-cited information indicates that Pesto, particularly the formulation for acute use, generally starts to soothe muscle spasms within approximately 15 minutes. This quick onset allows it to be used for sudden, painful cramping.

Q: What should I do if I miss a dose of Pesto?

A: Official instructions typically state that if a dose is missed, it may be taken as soon as the user remembers. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. A double dose must not be taken to make up for a missed one.

Q: Can Pesto be taken with over-the-counter pain relievers like ibuprofen?

A: Regulatory documents list known pharmacodynamic interactions with specific drug classes, such as other anticholinergics and dopamine antagonists. Official product information does not specifically document an interaction with non-anticholinergic, non-opioid pain relievers like ibuprofen.

Q: Is Pesto addictive or habit-forming?

A: Official drug classification documents for the active ingredient, hyoscine butylbromide, indicate that it is not classified as a controlled substance under United States regulatory categories. This classification suggests the drug does not have the same dependence or abuse concerns as controlled substances.

Q: Are there any long-term side effects of Pesto that I should be aware of?

A: The drug is constrained to short-term use in many regulatory guidelines. While the most commonly reported effects are mild and temporary, patients should remain aware of potential anticholinergic side effects with use, such as urinary retention, dry mouth, or changes in vision.

Q: Can Pesto interact with vitamins or herbal supplements?

A: Official drug information for Pesto states that no specific interactions are formally documented with food or herbal products. As with any medication, combining Pesto with supplements is a matter for individual medical review.

Q: Are there requirements for monitoring while taking Pesto, like blood tests?

A: Routine blood tests are not specified in the regulatory documentation for Pesto. However, regulatory warnings indicate that a painful, red eye with loss of vision while taking the drug is a signal that requires immediate medical evaluation.

Q: Does Pesto have a 'half-life,' and what does that mean?

A: Yes, Pesto has a pharmacologically defined 'half-life,' which is a term that describes how quickly the drug is cleared by the body. Regulatory documents state the terminal elimination half-life is approximately 5 hours after injection. This time frame informs the typical timing of administration.

Q: Why do some people take Pesto at night and others in the morning?

A: Pesto is generally taken multiple times daily, often three to five times a day. The timing of administration often depends on when an individual anticipates symptoms or requires relief, as it is a short-acting treatment for spasm.

Q: Do I need a prescription to get Pesto?

A: The regulatory status of Pesto (hyoscine butylbromide) varies depending on the country or region. It is classified as Prescription-Only Medicine (POM) in some regions, while in others, it may be available as a Pharmacist or General Sales List medicine.

Q: Is it normal to feel tired when first starting Pesto?

A: Drowsiness is not listed as a common adverse reaction in official product information, but it is a potential side effect that has been reported. Users should be aware that it can occur, particularly in sensitive populations.

Q: Are there any specific foods or drinks I should avoid while taking Pesto?

A: Official documentation advises that the consumption of alcohol may increase the chance of side effects, particularly drowsiness. No specific food restrictions are formally documented in the product information.

Q: Can elderly people use Pesto?

A: Use is generally allowed in the elderly population. However, regulatory warnings indicate that the elderly may have an increased sensitivity to anticholinergic side effects or central nervous system effects.

Q: What happens if I stop taking Pesto suddenly?

A: Regulatory information indicates that patients are often instructed not to stop Pesto without consulting a healthcare professional first. Since the drug is used for symptomatic relief of spasm, sudden discontinuation may result in the return of symptoms.

Q: Does Pesto affect my ability to drive or operate machinery?

A: Regulatory warnings indicate that patients should be cautious about driving or operating machinery, as visual disturbances, dizziness, or drowsiness are possible effects. This caution is based on potential changes to alertness.

Q: Is Pesto a controlled substance?

A: Official regulatory documents confirm that the active ingredient in Pesto, hyoscine butylbromide, is not classified as a controlled substance under United States federal regulations.

Q: Can I take Pesto if I have a history of liver problems?

A: The drug must be used with caution in patients who have impaired liver function. Official warnings state that adverse effects on the central nervous system are more likely in individuals with existing liver problems.

Q: Is there a generic version of Pesto available?

A: Yes, the active ingredient, hyoscine butylbromide, is available as a generic name. This generic component is used in numerous approved antispasmodic products across different regulatory regions globally.

Q: Can Pesto be crushed or split in half?

A: Product information for the tablet formulation often advises patients not to break, crush, or chew the tablets. This guidance is provided to maintain the intended function of the formulation.

Q: What are the signs of a serious allergic reaction to Pesto?

A: Official documents list signs of severe allergic reactions (anaphylactic shock) that may include difficulty breathing, feeling faint or dizzy, and severe skin reactions. Severe symptoms like swelling or difficulty breathing are signals that require immediate medical evaluation.

Q: Are there different strengths of Pesto?

A: Yes, Pesto is available in different strengths and forms. These commonly include oral tablets (e.g., 10 mg and 20 mg) and a solution for injection (e.g., 20 mg/mL) to suit different administration routes.

Q: Does taking Pesto affect fertility in men or women?

A: Official regulatory documents indicate that no specific studies have been conducted to evaluate the effects of Pesto on human fertility. This means there is insufficient data to provide a definitive statement on this matter.

Q: Is Pesto approved for children or teenagers?

A: Oral tablets of Pesto are generally approved for children aged 6 years and older, with specific dosing guidelines for the 6-12 age group. It is not recommended for use in children under 6 years of age.

Q: What are the official restrictions on who can use Pesto?

A: Official restrictions (contraindications) define the conditions under which Pesto must not be used. These include specific conditions like narrow-angle glaucoma, myasthenia gravis, megacolon, and mechanical stenosis in the gastrointestinal tract.

Q: Does Pesto change blood pressure or heart rate?

A: Official information states the drug is associated with an increased heart rate (tachycardia) and can enhance the tachycardic effects of certain other medicines. Caution related to cardiac conditions is mentioned in the regulatory warnings.

Q: Can Pesto cause dry mouth or changes in vision?

A: Yes, dry mouth is listed as an uncommon adverse effect. Changes in vision, such as temporary blurred vision or disturbances of the accommodation reflex, are also known side effects related to its anticholinergic action.

Q: What if Pesto doesn't seem to be working for me after a few weeks?

A: Official product information advises that if symptoms worsen, new symptoms develop, or if symptoms have not improved over approximately two weeks, the regulatory guidance indicates that a consultation with a pharmacist or physician is appropriate.

Q: Does Pesto affect my mood or cause anxiety?

A: While not primary side effects, isolated reports have noted central nervous system effects such as confusion, agitation, and hallucinations. These effects have mainly been observed in cases of overdose or in sensitive individuals, such as the elderly.

Q: Is Pesto known to cause any skin reactions?

A: Yes, skin reactions are listed as known adverse effects in regulatory documentation. These reactions may include urticaria (nettle rash), pruritus (itching), and general rash.

Q: What are the conditions under which Pesto is not recommended?

A: Pesto is not recommended for patients who have specific conditions defined as contraindications, such as narrow-angle glaucoma or megacolon. Additionally, it is generally not recommended for certain populations like pregnant or breastfeeding women due to limited data.

How should Pesto be stored and disposed of?

The storage and disposal of Pesto (Hyoscine Butylbromide) must follow specific regulatory requirements to ensure product stability and safety. Tablets must be stored in the original package and kept dry, protected from light, generally at temperatures below 25 C or 30 C. The injection solution should be used immediately after opening the single-use ampoule, and any diluted solution is stable for only 24 hours.

All forms of the medicine must be stored out of the sight and reach of children.

For disposal, unused or expired Pesto must not be thrown away via wastewater or household waste. It must be discarded in accordance with local requirements, and patients should consult a pharmacist for the proper disposal method.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pesto found in:

A-Z Index: